Glenmark Pharmaceuticals has discovered a new drug molecule, which could be used for treating pain and respiratory disorders. The new drug molecule, codenamed ‘GRC 17536’, has completed pre-clinical trials (animal tests) and will move into clinical trials (tests on humans) in the first quarter of 2011.
GRC 17536 is another potential first-in-class globally and the results shown by the molecule in animal studies is encouraging. It has proven highly efficacious in treating inflammatory and neuropathic pain in animal models, compared to gold standard drugs. Glenmark has already filed multiple patent applications for these molecules. The company’s Novel Chemical Entity (NCE) programme is targeting pain and respiratory disorders.
crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1234.85 |
| Cipla | 1211.95 |
| Zydus Lifesciences | 923.25 |
| Lupin | 2315.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: